Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.
Beskrivning
SpringerBriefs in Biotech Patents present timely reports of intellectual properties (IP) issues and patent aspects in the field of biotechnology. The second chapter gives an overview of the patent landscape in molecular diagnostics, and discusses issues of patentability with respect to the different technologies and compounds used therein.
Dr. Ulrich Storz was born in 1969 in Muenster. He graduated in Biology at the University of Muenster in 1998, where he received his PhD in 2002. He is author and co-author of several scientific publications in the field of biology and biophysics as well as of several juridical publications in the field of intellectual property. He passed the German Patent Bar Examination in 2005. Since 2005, he has been admitted to practice as European Trademark Attorney at the European Trademark Office (OHIM). In 2006, he has been registered in the list of representatives before the European Patent Office. Main practice areas in the field of Intellectual Property Law include Patent Prosecution, FTO and Patent Infringement, as well as Patent strategies; especially in the Life Science field (i.e. Biotechnology, Biophysics, Biochemistry, microbiology). One of his major fields of interest is Antibody IP. Ulrich Storz is active as a speaker for the congress management company "Forum Institut für Management GmbH", and he organizes the annual Rhineland Biopatent Forum.
Innehållsförteckning
Ulrich Storz: IP Issues of Therapeutic Antibodies.- Wolfgang Flasche: Peptide Vaccines and Peptide Therapeutics.- Johanna Driehaus: Patent Landscape in Molecular Diagnostics.